0 Σχόλια
0 Μοιράστηκε
467 Views
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Ροή Δημοσιεύσεων
- ΑΝΑΚΆΛΥΨΕ
-
Σελίδες
-
Ομάδες
-
Blogs
-
Forum
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Σχόλια 0 Μοιράστηκε 177 Views
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Σχόλια 0 Μοιράστηκε 35 Views
-
Global Brachytherapy Market to Reach $1.64 Billion by 2032, Growing at 6.97% CAGRMarket Overview The global brachytherapy market size was valued at USD 895.45 million in 2023 and is projected to reach from USD 957.86 million in 2024 to USD 1,642.09 million by 2032, growing at a CAGR of 6.97% during the forecast period (2024–2032). The global Brachytherapy market is witnessing swift transformation driven by new consumer behaviors, increased...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Σχόλια 0 Μοιράστηκε 61 Views
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Σχόλια 0 Μοιράστηκε 64 Views
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Σχόλια 0 Μοιράστηκε 236 Views
-
Precision Oncology: The 2026 Shift Toward Oral Small Molecules and Combination Targeted Regimens"Global Executive Summary Small Molecule Targeted Cancer Therapy Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global small molecule targeted cancer therapy market which was USD 75,960.00 Million in 2022, would rocket up to USD 124,772.24 Million by 2030 and is expected to undergo a CAGR of 6.4% during the forecast period. The Small...0 Σχόλια 0 Μοιράστηκε 536 Views
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Σχόλια 0 Μοιράστηκε 25 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)